Literature DB >> 36133895

A collaborative approach to hepatitis C testing in two First Nations communities of northwest Ontario.

David Smookler1,2, Anne Beck3, Brenda Head4, Leroy Quoquat4, Cheyanne Albany5, Terri Farrell6, Janet Gordon6, Nancy Thurston3, Lucy You1,2, Camelia Capraru1,2, Mike McKay5, John Kim7, Jordan J Feld1,2, Hemant Shah1,2.   

Abstract

Background: Two remote First Nations communities each collaborated with an urban-based liver clinic to organize wide-spread testing, followed by linkage to care for hepatitis C virus (HCV). Method: Involvement of community members was central to planning and conduct of the programs. Samples were obtained using dry blood spot cards (DBS). A week-long pilot study in Community 1 investigated the effectiveness of the program, using DBS. Community 2, being larger, more remote, and known to be endemic for HCV was more challenging. Three-week-long testing drives plus a stand-alone testing day were used to collect samples over 5 months. Public Health Agency (PHAC)'s National Laboratory for HIV Reference Services (NLHRS) received and tested the DBS samples for HCV and other blood-borne infections. Outcomes were measured by number of people tested, the quality of the tests, and community members' satisfaction with the program and retained knowledge about HCV, based on interviews.
Results: In Community 1, 226 people were tested for HCV over 4 days. 85% agreed to human immunodeficiency virus (HIV) testing as well. In Community 2, 484 people, one-half of the adult population, were tested. Surveys of participants showed food was the most significant draw, and Facebook the most effective way to inform people of the events. Interviews with staff and participants showed a high level of satisfaction.
Conclusion: The results suggest this is an effective approach to testing for HCV in unusually challenging settings. Lessons from the program include the power of community involvement; and the effectiveness of a highly targeted health initiative when developed through collaboration.
Copyright © 2022 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  First Nations health; VIRCAN; community-led initiatives; dried blood spot (DBS)

Year:  2022        PMID: 36133895      PMCID: PMC9473560          DOI: 10.3138/canlivj-2021-0031

Source DB:  PubMed          Journal:  Can Liver J        ISSN: 2561-4444


  9 in total

1.  Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine-naloxone substitution therapy in the context of a First Nations healing program.

Authors:  Dinah Kanate; David Folk; Sharon Cirone; Janet Gordon; Mike Kirlew; Terri Veale; Natalie Bocking; Sara Rea; Len Kelly
Journal:  Can Fam Physician       Date:  2015-02       Impact factor: 3.275

2.  First Nations hepatitis C virus infections: Six-year retrospective study of on-reserve rates of newly reported infections in northwestern Ontario.

Authors:  Janet Gordon; Natalie Bocking; Kathy Pouteau; Terri Farrell; Gareth Ryan; Len Kelly
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

Review 3.  Epidemiology of viral hepatitis and HIV co-infection.

Authors:  Miriam J Alter
Journal:  J Hepatol       Date:  2005-11-21       Impact factor: 25.083

4.  Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999-2004.

Authors:  H-X Wu; J Wu; T Wong; A Andonov; Q Li; K Dinner; T Donaldson; S Paton
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

5.  In the eyes of Indigenous people in Canada: exposing the underlying colonial etiology of hepatitis C and the imperative for trauma-informed care.

Authors:  Sadeem T Fayed; Alexandra King; Malcolm King; Chris Macklin; Jessica Demeria; Norma Rabbitskin; Bonnie Healy; Stewart Gonzales Sempulyan
Journal:  Can Liver J       Date:  2018-10-03

6.  Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time.

Authors:  Lauren Lapointe-Shaw; Hannah Chung; Beate Sander; Jeffrey C Kwong; Laura Holder; Orlando Cerocchi; Peter C Austin; Jordan J Feld
Journal:  Liver Int       Date:  2021-01       Impact factor: 5.828

Review 7.  Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.

Authors:  Berit Lange; Jennifer Cohn; Teri Roberts; Johannes Camp; Jeanne Chauffour; Nina Gummadi; Azumi Ishizaki; Anupriya Nagarathnam; Edouard Tuaillon; Philippe van de Perre; Christine Pichler; Philippa Easterbrook; Claudia M Denkinger
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

8.  The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.

Authors:  Stephanie Popping; Debora Bade; Charles Boucher; Mark van der Valk; Manal El-Sayed; Olafsson Sigurour; Vana Sypsa; Timothy Morgan; Amiran Gamkrelidze; Constance Mukabatsinda; Sylvie Deuffic-Burban; Michael Ninburg; Jordan Feld; Margaret Hellard; John Ward
Journal:  J Virus Erad       Date:  2019-01-01

9.  The impact of infection on population health: results of the Ontario burden of infectious diseases study.

Authors:  Jeffrey C Kwong; Sujitha Ratnasingham; Michael A Campitelli; Nick Daneman; Shelley L Deeks; Douglas G Manuel; Vanessa G Allen; Ahmed M Bayoumi; Aamir Fazil; David N Fisman; Andrea S Gershon; Effie Gournis; E Jenny Heathcote; Frances B Jamieson; Prabhat Jha; Kamran M Khan; Shannon E Majowicz; Tony Mazzulli; Allison J McGeer; Matthew P Muller; Abhishek Raut; Elizabeth Rea; Robert S Remis; Rita Shahin; Alissa J Wright; Brandon Zagorski; Natasha S Crowcroft
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.